By using a mixed regression model of repeated measures (AR-1) controlling for age, gender, and HAMD-17 mean sum score at screening, significant differences were found comparing the HAMD-17 mean sum scores of "Week 0" with the corresponding scores at the "Week 3" (t = −2.05, p = 0.045) and "Week 4" visit (t = −2.77, p = 0.008).
After screening for significant differences (within this experiment) between the mean normalized Ct values (Student's t-test, p > 0.05, n = 3), between differentiated and undifferentiated samples, 87 genes (82%) had differences in expression.
This effect represents a significant marginal increase over significant temporal trends in FOBT screening and significant differences in screening between provinces, as indicated by the time and group coefficients, respectively.
The DsbG* mutants isolated from the PhoA* screen have significant differences in their in vivo substrate specificity and in their capacity to protect cells from copper toxicity.
Even though the screening revealed significant differences in fermentation of hydrolysate, it is important to evaluate the microbial performance in the whole slurry in a SSCF process.
In comparisons of cancers detected at prevalence and incidence screens, as a test of conformity with screening theory, no significant differences were apparent according to size and lymph node status, yet the characteristics of histological type of cancer discriminated significantly (P less than 0.05).
Further screening experiments revealed significant differences in RWCs and RECs among the four soybean genotypes under dehydration and rehydration conditions.
Analyses of the children and adolescents who dropped out of the study after the screening revealed no significant differences compared with participants in the clinical examination in psychometric measures.
Initial data screening revealed no significant differences between treatment and control groups at time one in terms of age (F 1, 27) = 0.28, p > 0.05), phobic avoidance (F 1, 27) = 1.58, p > 0.05), phobic severity (F 1, 27) = 2.30, p > 0.05), or anxiety as measured by the GAI (F 1, 26) = 0.25, p > 0.05).
Association results with the pooled DNA method and following re-genotyping of individual DNAs using the same set of 1,000 screened individuals, 23 markers showed significant differences by Fisher's exact test (Table 1).
